Pfizer, Seagen Merger Tops Largest M&A Deals Of 2023
Pfizer's $43 billion purchase of Seagen Inc., revealed in March, still stands as the largest global merger or acquisition announced in the first half of 2023, which featured a number of...To view the full article, register now.
Already a subscriber? Click here to view full article